Official Title: “Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004%”

To compare the diurnal curves in patients using bimatoprost 0.03% versus travoprost 0.004% for the treatment of glaucoma or ocular hypertension.

Study Type: Interventional

Study Design: Randomized, Single Blind, Active Control, Parallel Assignment

Intervention(s) in this Clinical Trial

• Drug: Bimatoprost 0.03%, Travoprost 0.004%

Inclusion Criteria:

• · Male or female > 18 years of age
• Naive to treatment or washed off any ocular hypotensive agents
• Untreated IOP >19 mm Hg
• Diagnosis of open-angle glaucoma or ocular hypertension
• Ability to provide informed consent and likely to complete study

Exclusion Criteria:

• · Known contraindication to bimatoprost or travoprost, or any component of any study medication
• Uncontrolled systemic disease
• Active ocular disease other than glaucoma or ocular hypertension
• Required use of ocular medications other than the study medications during the study
• History of intraocular surgery within the last 3 months
• Prior discontinuation of any of the study medications for reasons related to efficacy or safety

Gender Eligibility for this Clinical Trial: Both

Minimum Age for this Clinical Trial: 18 Years

Maximum Age for this Clinical Trial: N/A

Lead Sponsor: Innovative Medical

Overall Clinical Trial Officials and Contacts

Robert Noecker, MD Principal Investigator UPMC Eye Center  

Information obtained from ClinicalTrials.gov on October 10, 2008

Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00347802

Study ID Number: 5176

ClinicalTrials.gov Identifier: NCT00347802

Health Authority: United States: Institutional Review Board